Health

AI is coming to a hospital near you — but it may be in the world’s remote regions that it could impact patients most. However, experts gathered at Harvard said its potential will not be realized unless it is deployed as part of broader health care solutions, not simply as a tool in search of problems.

Considering a new strategy for malaria control that complements existing insecticide-treated bed nets, a Harvard-led study found that mosquitoes landing on surfaces coated with the antimalarial drug atovaquone were blocked from developing the parasite that causes the disease.

Overlapping surgeries, in which more than one doctor performs sequential surgeries in different operating rooms, have raised concerns about potential adverse outcomes — but a new analysis shows they carry no greater risk for low-risk, noncardiac patients.

Analysis of data from the Nurses’ Health studies shows quitting smoking may reduce the risk of the severest form of rheumatoid arthritis.

Three years after undergoing gene therapy at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center to treat a life-threatening immune disorder, an Ohio college student is no longer thinking about his own “last shot” for health, but rather about medical school and “giving back.”

A new study from the Blavatnik Institute finds that intense exercise and fasting activate hormones that boost cells’ capacity to dispose of defective proteins, which clog up the cell, interfere with its functions, and, over time, precipitate diseases including neurodegenerative conditions such as ALS and Alzheimer’s.

Harvard Chan School of Public Health researchers are engaging with some of the world’s most recognizable brands to improve working conditions and workplace well-being around the world.

Harvard researchers have found that the number of pushups middle-aged men can do may be a useful, no-cost tool to help clinicians assess cardiovascular disease risk during routine examinations.

Harvard researchers have discovered that a novel biomarker of aging in rDNA can accurately determine an individual’s chronological and biological age. The biomarker opens new opportunities for monitoring responses to interventions and lifestyle choices.

A team of researchers at the Wyss Institute at Harvard University and several collaborating institutions has created a drug-free, reversible antiplatelet therapy that uses deactivated “decoy” platelets to reduce the risk of blood clots and potentially prevent cancer metastasis.

Harvard researchers found that interaction between immune factors triggers cancer-promoting chronic inflammation, setting the stage for the development of skin cancer associated with chronic dermatitis and colorectal cancer in patients with colitis.

By exposing stem cell-derived kidney organoids to fluidic shear stress, A team of Harvard researchers has significantly expanded the organoids’ vascular networks and improved the maturation of kidney compartments.

A team of investigators from Harvard-affiliated Brigham and Women’s Hospital, MIT, and Novo Nordisk has developed a microneedle pill that can deliver an oral formulation of insulin that can be swallowed rather than injected.

The combination of the antibody CD117 and the drug saporin selectively targets blood stem cells, making transplantation safer by limiting collateral damage caused by the current standard of treatment, chemotherapy, and radiation.

A half-day conference at Harvard Business School examined the growing promise of research on aging and the potential of now-experimental interventions to one day ease the burdens of infirmity.

Amid projections that global cancer rates will skyrocket, researchers from around the country gathered at Harvard Monday to share their latest findings and to launch a center whose aim is to boost cancer early detection and prevention.

Health care spending among the Medicare population age 65 and older has slowed dramatically since 2005, and as much as half of that reduction can be attributed to reduced spending on cardiovascular disease, a new Harvard study has found.

A project to write songs using individual soldiers’ combat experiences appears to help them overcome haunting memories of war, lessening the impact of trauma held too close for too long.

A new study finds two chemicals commonly used to flavor e-cigarettes may be damaging cilia production and function in the human airway.

Scientists at the Harvard Stem Cell Institute are seeking ways to protect newly transplanted cells from autoimmune attack.

A new study finds that being genetically programmed to rise early may lead to greater well-being and a lower risk of schizophrenia and depression.

Proteins produced by the tardigrade are suspected of playing a role in the organism’s resilience, ultimately providing the basis for human therapies that halt tissue damage and prevent cell death.

Reliving happy memories and anticipating pleasure boosted the moods of people recovering from addiction in a study conducted by researchers at MGH’s Recovery Research Institute who eye such exercises as a potential treatment tool.

In a new study, researchers found that African-Americans who experienced moderate to high financial stress had an increased risk of developing heart disease compared with those who did not report such stress.

Study finds virtual video visits, one form of telehealth visit used at MGH, can successfully replace office visits for many patients without compromising the quality of care and communication.

In the largest study of U.S. twins to date, researchers use insurance records to tease out the effects of genes and the environment in 560 diseases.

A new study from MassGeneral Hospital for Children looks at how people with Down syndrome continue to learn.

Figure out what resolutions fit your lifestyle and then make them happen with some expert advice.

A new study from Brigham and Women’s Hospital finds that pregnant women taking the common anti-nausea medication ondansetron during the first trimester have no increased risk of cardiac malformations and only a slight increased risk of oral clefts.

Amid studies showing e-cigarette use rising rapidly among teens, public health officials who recognize the devices’ potential to reduce health hazards discuss the need to tailor their message to keep the devices out of the hands of the young, according to the head of Harvard’s Center for Global Tobacco Control.